September 01, 2020
Drugmaker Biogen Inc. saddled employees with high-cost, underperforming mutual funds through its Fidelity-managed retirement plan in a "glaring breach" of fiduciary duty, according to a proposed class action suit filed Monday in Massachusetts federal court.